CSPG4 and breast carcinoma: However, the binding of VT68.2, but not 225.28, to cells was inhibited by N-glycosidase treatment (Figure 1A,C), indicating that N-linked glycans contribute to VT68.2 reactivity with CSPG4 on MDA-MB-231 breast cancer cells.